FTC Chair Plans to Explore All Options in PBM Investigations

The chair of the US Federal Trade Commission (FTC), Lina Khan, has pledged to use all the tools at her disposal to investigate the practices of pharmacy benefit managers (PBMs), which have recently faced increasing scrutiny. This is due to allegations of anti-competition and price fixing. A formal investigation by the agency was announced this summer.

According to Paul Schloesser, “In response to a question about whether there are laws that prohibit certain anti-competitive behavior allegedly done by PBMs, Khan answered in the affirmative, noting two laws that were passed decades ago that have not been utilized in recent memory by the commission. However, those laws were passed before a philosophy shift in terms of what defines antitrust.”

To read more, click here.

(Source: Endpoints News, October 3^rd, 2022)